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Hearing loss is a genetically and clinically heterogeneous defect and more than 140 loci 
and 65 genes have been identified to cause autosomal recessive non-syndromic hearing 
loss (ARNSHL). According to the previous studies, mutations in GJB2 are estimated to 
be involved in 18.17% of ARNSHL cases in the Iranian population; as a result, the 
remaining 81.83% of this disorder is yet ambiguous. This study aimed to determine the 
contribution of DFNB3 in hearing loss as well as the frequency of gene mutations in a 
population (Arab tribal origin) in the Southwest of Iran. 
 In this descriptive laboratory study, we included 25 families from the Southwest of Iran 
and negative GJB2 gene. Linkage analysis was performed by DFNB3 (MYO15A) 
molecular markers (STR). The families with hearing loss linked to this locus were further 
analyzed for mutation detection. MYO15A gene exons were amplified and analyzed using 
direct DNA sequencing. 
 In studied families, one family displayed linkage to DFNB3 locus. Identified mutations 
include substitution and substitute C for A in 1047 location of coding region of MYO15A 
gene (c.1047 C>A) in exon 2 which cause to change Tyrosin to stop codons (P.Y349X), 
results in the premature truncation at amino acid position 349. 
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INTRODUCTION 
Deafness, the inability to hear, is the most prevalent genetic sensory disorder in human 
populations that can significantly impact quality of life style (HILGERT et al., 2009). Globally it is 
estimated that it affects 1 in 500 child births but the prevalence of HL in Iran was 2–3 times higher 
than that in other parts of the world (MAHDIEH et al. 2010).The majority of cases are attributable to 
genetic factors. 
There is different type of genetic transmission such as, autosomal recessive (ARNSHL) 
(75–85%), autosomal dominant (15–25%) (ADNSHL), Xlinked and mitochondrial inheritance (1–
2%) (TABATABAIFAR et al., 2011; DAMAN 2012). 
ARNSHL is the most common type of inherited hearing loss and it is genetically 
heterogeneous. To data, 65 genes and more than140 loci have been identified to cause ARNSHL 
(LIBURD et al., 2001; RICHARDSON et al., 2011). Recessively inherited phenotypes are common in 
the Iranian population as the result of a high frequency of consanguineous marriages accounts for 
~38% (TABATABAIEFAR, ALASTI et al. 2011). Iranian families expressing such traits have 
cooperated with research studies to identify the critical genes for many phenotypes.  
MYO15A, located on 17p11.2, has 66 exons and it is coding myosin XVa (myosin heavy-
chain-15A) protein. This protein is composed of 3,530 amino acids, and has different functions 
such as transcription factors, cell adhesion molecules, ion channels (LIBURD et al., 2001; DROR 
2010), and critical role for the formation of stereocilia in hair cells of the cochlea. It is localized at 
the tips of stereocilia that functions as a motor protein uses energy from ATP hydrolysis to move 
along actin filaments in the stereocilia of hair cells (BASHIR et al., 2012; WOO et al., 2013). 
Mutations in this large gene can cause hearing loss in individuals from different 
populations worldwide. The aim of this project is to study the prevalence of MYO15A mutations in 
negative connexin 26 patients. Here, we report a family with five siblings affected by severe 
sensorineural hearing loss. As the family is consanguineous, either linkage analysis would have 
been informative for identifying the causative gene. This is the first study to identify MYO15A 
mutations as the ARNSHL-associated gene in population (Arab tribal origin) in the Southwest of 
Iran. 
 
MATERIALS AND METHODS 
Clinical evaluation 
Clinical histories of patients such as age of hearing loss (pre-lingual, post-lingual), 
severity of hearing loss (mild, moderate or profound) and pattern of hearing loss were obtained 
from patient records and deafness informational questionnaires were filled out for all families and 
the pedigrees were drawn based on the filled-out questionnaires then written consent was obtained. 
Speech-reception thresholds and pure-tone audiograms were obtained from patient. Pure-tone 
audiometry test was performed with air conduction at 250 to 8000 Hz, and bone conduction was 
performed at 250 to 4000 Hz.  
All families were negative for the vestibular signs and symptoms and none of them 
showed any syndromic features. Besides, diabetes, cardiovascular diseases, visual problems and 
neurological disorders were also excluded.  
We included 25 Iranian Arab families with at least four siblings affected by severe-to-
profound sensorineural hearing loss from the southwest provinces of Iran with no connexin 26 
mutation. 
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Preparation of DNA 
All genomic DNA was extracted from EDTA-containing blood samples of participating 
all members of families using the phenol/chloroform standard procedure (WOO et al., 2013). 
The quality and quantity of extracted DNA were checked on agarose gel and a Nano-Drop 1000 
spectrophotometer (Thermo Scientific Inc., Wilmington, DE, USA). 
 
Slink calculation, DFNB3 STR marker genotyping  
Power of the pedigrees for linkage analysis was simulated by calculating SLINK, using 
Fast S-Link ,version 2.51 (FISHELSON et al., 2004; LINDNER and HOFFMAAN 2005). Two point and 
multi-point parametric logarithm of odds (LOD) scores were calculated by Superlink version 1.6 
and Genehunter version 2.91. For LOD score calculations, inheritance model of autosomal 
recessive, complete penetrance and disease-allele frequency of 0.001 were assumed (FISHELSON 
and GEIGER 2004). After linkage analysis, STR markers haplotypes were reconstructed by 
SimWalk then visualized using Haplopainter ver. 029.5 software (THEIEHE and NURNBERG 2005). 
For linkage analysis of the DFNB3 locus, 5 different short tandem repeat (STR) markers were 
used. The criteria for selecting STR marker include greater heterozygosity values (HZ>50%), 
shorter amplicon and locating near the DFNB3 locus. Selection of STRs and their primers were 
based on their physical distance, available at NCBI Map Viewer and NCBI UniSTS.  
 
Table1. STR markers used and their characteristics. 
 
 
PCR and linkage analysis 
The used markers are shown in table 1. Polymerase chain reaction (PCR) amplification of 
STR markers was performed as follow: 8 μL of Master Mix 2x (containing, MgCl2, AmpliTaqTM 
Gold DNA polymerase, and dNTPs (Applied Biosystems)), 0.45 μL of each of the primers (10 
pM), 2 μL DNA (50 ng), adjusted to 18 μL using ddH2O.  
Marker Physical 
Position (bp) 
PCR 
product 
 
Forward primer  
(5'→3') 
Reverse primer  
(5'→3') 
HZ 
D17S921 14,357,388 - 
14,357,565 
178 (bp) CTTGGACTCCTACAAATCCTGGCA GGCCACCATAATCATGTCAGACAAT 
0.72 
D17S1843 16,161,201 - 
16,161,399 
 
199 (bp) AATTCAAAGGCTAAAAGCAAAC 
 
GAGAATCACCTGAACCCG 
 
0.70 
D17S953 16,199,132 - 
16,199,442 
 
123 (bp) ACTATCCGCCCAATACA AAGGGCTTGCTTTGAC 
0.81 
D17S2196 17,361,168 - 
17,361,304 
 
137 (bp) CCAACATCTAGAATTAATCAGAATC ATATTTCAATATTGTAACCAGTCCC 
0.81 
D17S620 
 
17,676,432 -
17,676,573 
 
142 (bp) GAAGGTGTCTGAAACCCAAGG 
 
CCCACCACTACCTATTGTTCTATAC 
 
0.53 
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For amplification, PCR program was used: an initial denaturation at 94°C for 5 minutes, 
and 30 cycles of 95°C for 30 seconds (denaturation), 60°C for 30 seconds (annealing), 72°C for 50 
seconds (extension) and a final extension at 72°C for 5 minutes. PCR products were loaded on a 
12% polyacrylamide gel electrophoresis (PAGE) and run at 35 mA for 2-6 hours, Silver staining 
was performed to visualize the bands on the gel following standard protocols, (In different stage , 
for various primers some modifications were applied).  
 
Mutation screening of MYO15A 
All 66 exons were amplified using primers designed by Oligo ver. 6.7.1.0 (National 
Biosciences Inc., Plymouth, MN, USA). 
Amplification was performed, with some modifications for each amplicons, in a 50 μL 
volume of reaction, containing 24 μL of Master Mix 2x, 0.8 μL of each primer (10 pM), 4 μL 
DNA (50 ng), 20 of ddH20. PCR was done according to the following program: an initial 
denaturation at 95°C for 4 minutes, 30 cycles of 94°C for 30 seconds (denaturation), 61-65°C for 
30 seconds (annealing), 72°C for 1 minute (extension) and a final extension at 72°C for 5 minutes. 
DNA sequencing of the PCR-amplified product was performed bi-directionally on an ABI 
3730XL automated sequencer (Applied Biosystems, Macrogen and, Seoul, Korea) then detect any 
variant in the gene sequence using Seqmqn soft ward analyser. 
 
 
RESULTS  
In this study, most of the subjects displayed bilateral, severe to profound sensorineural 
HL, and most of families were consanguineous, audiological characterization of all patients is 
shown in figure1. 
 
 
            
 
Figure 1. Audiograms of patients in family And-1. A: Audiograms of left ear, B: Audiograms of right ear. 
 
Estimated maximum Slink for these 25 families ranged from 1.2 to 4, two point and multi 
point LOD and S-link scores related to this family are indicated in table 2. In haplotype analysis, 
one of the 25 families from khosestan province in southwest of Iran showed linkage to the DFNB3 
locus (Figure. 2). Linkage to the locus was confirmed by molecular markers on electrophoresis gel 
(Figure.3). 
 
B A 
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Figure 2. Pedigree and haplotype of And-1 family. The order of markers is based on the Marshfield map. This 
family shows linkage to the DFNB3 locus. 
 
 
 
 
Table 2. S-Link and LOD scores calculated for family linked to DFNB3. 
Family  S-LINK Two point LOD score Multipoint LOD score 
Iranian Family And-1 3.75 1.75 1.9 
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Figure 3. Results from DNA PAGE.  A: STR alleles of D17S620 (lane 1, 2, 4: affected children 
(Homozygote), lane 3: healthy child (Heterozygote), lane 5: mother (Heterozygote)). 
                B: STR alleles of D17S1843 (lane1: healthy children (Homozygote), lane 2, 3, 4: 4: affected 
children (Homozygote) and lane 5, mother (Heterozygote)). 
 
 
DNA sequencing of the MYO15A gene revealed a variant in exons 2 homozygous state in 
Family And-1 (Figure 4). This variant was nonsense substitution and substitute C for A in 1047 
location of coding region of MYO15A gene (c.1047 C>A) which cause to change Tyrosin to stop 
codons (P.Y349X). The mutation segregates within the family according to a recessive pattern of 
inheritance in which the patient is homozygous for the mutated allele. The mother carries this 
mutation at the heterozygous state. 
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Figure 4. Sequencing chromatograms of MYO15A variants (c.1047C>A). Wild type, heterozygous and mutant 
alleles of respective deafness genes for a normal control (A), an affected (B) and carrier (C) 
member of family And-1. 
 
DISCUSSION 
GJB2 mutations are responsible for 50% of HL in Caucasian populations, whereas the 
mean frequency of GJB2 mutations among the Iranian deaf groups is > 18.17% (MAHDIEH et al., 
2004). The frequency of GJB2 mutations the Iranian deaf groups decreases gradually both west to 
east and north to south (ROBBANI et al., 2010) and the frequency of this gene in Khuzestan 
provenance is 13% (HOSSEINIPOUR et al., 2005). The specific position of Iran and the existence of 
various ethnic groups (such as, Persian, Azeri, Kurd, Lur, Arab, balooch, Gilaki, Mazandarani and, 
Turkmen) suggest the high heterogeneity throughout Iran, that intra group marriages may give rise 
to a high homogeneity in some mutations and loci within groups (BAGHERIAN et al., 2010). On the 
basis of this point, it can be concluded that other genes and mutations involved in causing 
deafness. However, ethnic and geographical variations should be an important factor for 
determining the most appropriate type of assay. 
The nonsense mutation (c.1047C>A (p.Y349X)) detected in MYO15A in family And-1, 
results in the premature truncation at amino acid position 349 located in the first domain (N-
terminal extension) of the myosin XVa protein, which is normally comprised of 3530 amino acids.  
Myosin XVa is present at the very tip of each stereocilium in the developing and mature 
hair bundles of the cochlear and vestibular system. Mutant this gene produces defective protein, 
resulting in abnormally short stereocilia in hair bundles (MICHEL et al., 2005). 
 In this investigation, one of the 25 families was link to DFNB3 (MYO15A gene) ~ 4% of 
Arab population in Southwest Iran. 
A 
B 
C 
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In Iran, FATTAHI, et al. in 2011 performed linkage analysis of DFNB3 in 140 families 
with ARNHL, 8 families showed linkage to the DFNB3 locus, suggesting a MYO15A mutation 
frequency of  5.71% in this cohort of Iranian population ( Fars, Azeri, kord, Sistani ) (FATTAHI et 
al., 2012).  
 In 2002, FRIEDMAN et al. reported that 5% responsible of hearing loss in Pakistan was 
associated with MYO15A (HINNANT et al., 2002) and, the frequency of MYO15A related deafness 
in Turkey has been reported about 9.9% (HINNANT et al., 2002, SIRMACI et al., 2011). Considering 
the relatively high frequency of MYO15A related deafness in countries neighboring Iran (Pakistan 
and Turkey), the frequency of 5.71% was reasonable (FATTAHI et al., 2012). MYO15A mutation 
frequency of in our cohort (Arab population) was near to frequent reported by Fattahi.  In present 
investigation, we find a mutant allele of MYO15A had five deaf individuals in two consanguineous 
marriage loops and was linked to this region with a simulated Lod score of 1.7. Patients and 
parents were homozygote and heterozygote, respectively, for this mutation. 
The interesting point of our result was ethnic of our population (Arab), sequence analysis 
of MYO15A gene in 130 families showed this novel variant (c.1047 C>A) (P.Y349X) in exon 2, in 
Saudi Arabian tribal origin for first time, then reported present study in Iranian Arabian tribal 
origin. Brownstein al. in 2011, employing targeted DNA capture and massively parallel 
sequencing (MPS), screened 246 genes known to be responsible for human deafness in 11 
probands of Israeli Jewish and Palestinian Arab origin , they reported 6 novel mutations, three of 
which related to MYO15A gene that they detected a deletion (c.373delCG (p.R125VfsX101)) 
mutations in exon 2 of MYO15A gene in Palestinian Arab origin from middle eastern families 
(TABIBAH et al., 2011), base of this report, its look, exon 2 may be hotspot region for Arab ethnic. 
Although, studies with more patients origin Arab in different country is needed.   
VOZZI et al. used Ion Torrent DNA sequencing technology to analyze 96 genes related to 
HL in 12 families coming from Qatar and reported 1 novels mutations in second exon of 
MYO15A gene ((c.453_455delCGAinsTGGACGCCTGGTCGGGCAGTGG) (p.E152GfsX81)) 
(Vozzi, Morgan et al. 2014). 
 In Iran, also FATTAHI,et al. in 2011 reported 7 novel mutations, including 4 missense 
mutations (c. 1387A>G; c.8467G>A; c.5810G>A), 1 nonsense mutation (c.5925G>A), and 2 
deletions (c.4904-4907delGAG, c.5419-21delT) in different regions of the myosin-XV protein  
(FATTAHI, SHEARER et al. 2012). 
In 104 unrelated multiplex and consanguineous Turkish families population, Basak 
Cengiz reported missense mutation (c.867C>G (p.Y289X)) in second exon using autozygosity 
mapping (DUMAN et al., 2010).  
There are several reports of second exon mutation in MYO15A gene in different 
populations of the Middle East, base of this reports, it appears that this exon can be considered as a 
hotspot exon, and considering that this gene is very large size (66 exon), exon 2 can be used as 
first-line candidate for screening MYO15A mutation in the populations of the Middle East 
countries. 
Our present investigation illustrates that in 4% of studied families, HL was associated 
with MYO15A gene. However, the cause of HL in the remaining 96% families is still unknown and 
more extensive studies may be necessary. Correspondingly, in order to gain more information on 
the exact molecular bases of HL, further studies on the different populations and other loci for the 
same populations have to be performed. 
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Izvod 
Gubitak sluha je genetički gubitak i klinčki heterogen efekat. Utvrđeno je više od 150 lokusa i 65 
gena koji izazivaju autosomalne recesivne nesindromske gubitke sluh. (ARNSHL). Prema 
prethodnim studijama, mutacije u GJB2 su utvrđene da su uključene u 18.17% of ARNSHL 
slučajeva u Iranskoj populaciji; kao rezultat preostalih 81.83% tog poremećaja je još uvek 
dvosmislen. Cilj ovih ispitivanja je određivanje doprinosa DFNB3 kako gubitku sluha tako 
učestalosti mutacija gena u Jugozapadnom delu Irana arapskog porekla. Identifikovane mutacije 
uključuju substituciju C sa A u 1047 lokacija kodirajućeg regiona .MYO15A gena (c.1047 C>A) u 
egzonu 2, koji izaziva promenu tirozina u stop koodonu (P.Y349X), što kao rezultat ima 
prevremenu skraćivanje u 349-oj poziciji aminokiselina.      
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